EAACI Congress 2025

Back

13 - 16 June 2025 Glasgow, United Kingdom

L-FT08 - Dermatology

Sunday 15 Jun, 12:45 PM - 13:45 PM Glasgow, United Kingdom

Dochart 1 Flash Talks

12:45

LP-003 Significantly Decreases CSU Disease Activity and is Well Tolerated: Top Line Results from a Phase 2 Trial

Hu Feng (China)

12:52

Burden of illness in adult patients with hereditary angioedema due to C1 inhibitor deficiency

Teresa Caballero (Spain)

12:59

Evaluation of Serum IL-35 Level in Patients with Chronic Spontaneous Urticaria: A case control study

Maryam Khoshkui (Iran, Islamic Republic of)

13:06

CD8+ Skin-Resident Memory T Cells Require TCR Signaling for their Persistence in a Mouse Model of Allergic Contact Dermatitis

Anders Funch (Denmark)

13:13

Poorly controlled chronic spontaneous urticaria is associated with significant clinical, humanistic, and economic burden

Pavel Kolkhir (Germany)

13:20

Briquilimab Demonstrates Rapid, Clinically Meaningful Disease-Control in Adults with Chronic Spontaneous Urticaria (CSU): Updated Results from a Phase 1b/2a Study

Martin Metz (Germany)

13:27

Rupatadine treatment improves disease control in patients with chronic spontaneous urticaria – results from the CURE registry

Pavel Kolkhir (Germany)

13:34

Treatment with Omalizumab in chronic spontaneous urticaria: experience in a tertiary hospital

Dinara Korshunova (Spain)

13:41

Cellular and Molecular Immunoprofiling of Lupus Panniculitis: Elucidating the Roles of Cytotoxic and skin homing T Cells, B Cells, and Complement Activation

Mohammadmilad Ameri (Switzerland)